Dec. 8, 2021– In the nearly three years since the Health Resources & Services Administration (HRSA) launched its 340B drug pricing program ceiling price website, 41 drug companies have acknowledged that they overcharged 340B hospitals, health centers, and clinics and would refund those affected. This contrasts with only seven such reports in the two years prior to the … [Read more...]
No Fooling: Drug Maker 340B Price Transparency Has Improved
April 1, 2020– The first of April is an opportunity for people to play good-natured pranks on their family and friends. But this year it also gives hospitals participating in the 340B drug pricing program a chance to reflect on something that is definitely not a joke – drug manufacturer pricing transparency has improved because of a federal website that went live a year ago … [Read more...]
A Healthy Dose of Sunlight for Drug Companies
April 1, 2019— Today is a very good day for safety-net hospitals and the patients in need who rely on them. After nine long years of delay and preparation, the federal government today launched a new secure website. The site will provide hospitals, clinics, and health centers participating in the 340B drug pricing program with information on the maximum amount – or ceiling … [Read more...]